Environment Impact of Medicines
This article was originally published in SRA
Sweden calls for EU legislation
You may also be interested in...
Suspension of heartburn remedy ranitidine looming in the EU as the European Medicines Agency stands by its original decision.
Novartis thwarts Sun’s efforts to commercialize nilotinib in India, though the Indian firm indicates that its actions are covered under a local Bolar-type provision and that it has no plans to market the oncology drug while the originator's patent stands valid.
Centus Biotherapeutics has received formal European Commission approval for its Equidacent biosimilar rival to Avastin.